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Background: Minimally invasive mitral valve surgery became an attractive option 
because of its cosmetic advantages over the conventional approach. The superiority 
of the minimally invasive approach regarding other aspects is still debatable. The 
aim of our study was to determine the potential benefits of minimally invasive 
mitral valve replacement with intraoperative video assistance over conventional 
surgery. 
Methods: This is a single-center prospective cohort study that included 60 patients 
with rheumatic heart disease who underwent mitral valve replacement. Patients 
were divided into two groups: group (A) included patients who had conventional 
sternotomy (n= 30), and group (B) included patients who had video-assisted 
minimally invasive mitral valve replacement (n= 30). Intraoperative and 
postoperative outcomes were compared between both groups.  
Results: Mortality occurred in one patient in the group (A). Cardiopulmonary bypass 
time was 118.93 ± 29.84 minutes vs. 64.73 ± 19.16 minutes in group B and A 
respectively (p< 0.001), and ischemic time was 102.27 ± 30.03 minutes vs. 53.67± 
18.46 minutes in group B and A respectively (P < 0.001). Ventilation time was 2.77± 
2.27 vs. 6.28 ± 4.48 hours in group B and A respectively (p< 0.001) and blood 
transfusion was 0.50 ± 0.63 vs. 2.83 ± 1.34 units in group B and A respectively (p< 
0.001).  ICU stay was 1.73 ± 0.64 days in the group (B) vs. 4.47 ± 0.94 days in group 
A (p< 0.001). Postoperative bleeding was 353.33 ± 146.77 ml in the group (B) vs. 
841.67 ± 302.03 ml in group A (p <0.001). No conversion to full sternotomy was 
reported in group B. In group (B), two cases (6.6%) required re-exploration for 
bleeding vs. four cases (13.2%) in group (A) (p=0.67). The hospital stay was 6.13 ± 
1.59 days in the group (B) vs. 13.27 ± 7.62 days in group A (p< 0.001). Four cases 
(13.3%) developed mediastinitis in group A and in the group (B), there was one case 
of acute right lower limb embolic ischemia. 
Conclusion: Video-assisted minimally invasive mitral operations could be a safe 
alternative to conventional sternotomy with the potential of lesser morbidity and 
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Introduction 
Median sternotomy is the standard approach 
for mitral valve surgery, which provides optimal 
operative exposure and global cardiac access. 
Minimally invasive mitral valve replacement had 
gained popularity because of the cosmetic 
advantages. Initially, minimally invasive mitral 
valve surgery was based on modifications of 
previously used incisions like parasternal incision 
and was performed under direct vision [1,2].  Then 
surgeons shifted to small incisions depending on a 
mixed direct and video-assisted view, which 
provided accepted mitral valve exposure, and it 
showed that mitral valve operations could be done 
as safely and precisely as through a larger incision 
[3,4]. With further experience, a shift to video 
assistance occurred entirely, and operations began 
to be performed using secondary vision with port 
access [5,6]. Recently, mitral valve replacement 
was performed robotically; however, the 
advantages of minimally invasive approaches over 
the conventional approach other than the 
cosmetic aspects are still debatable [7,8]. The aim 
of our study was to determine the potential 
benefits of minimally invasive mitral valve 
replacement with intraoperative video assistance 
over conventional surgery. 
Patients and Methods: 
After institutional review board (IRB) approval, 
we performed a single-center prospective cohort 
study including 60 patients with rheumatic heart 
disease who presented between 2017-2019 for 
mitral valve replacement (MVR). Patients were 
divided into two groups: group (A) included 
patients who had conventional sternotomy (n = 
30), and group (B) included patients who had 
video-assisted minimally invasive mitral valve 
replacement (n =30). We excluded patients with 
double valve disease, ischemic heart disease, and 
congenital heart disease, and re-operative 
surgeries. We compared intraoperative outcomes 
(cardiopulmonary bypass and ischemic times) and 
postoperative outcomes (ventilation time, 
bleeding, blood transfusion, ICU and hospital stay, 
pain, and hospital complications) between both 
groups.  
Preoperative data 
Preoperative data are summarized in Table 1. 
There was no significant difference in 
preoperative data between both groups. 
Operative technique 
Sternotomy group 
All patients in this group had operation 
through a median sternotomy using 
cardiopulmonary bypass, and antegrade 
crystalloid cardioplegia with systemic cooling. 
Mitral valve replacement was performed through 
left atriotomy, excision of the diseased valve was 
performed, followed by placement of non-
everting sutures (from the atrium to the ventricle), 
sutures were applied to the sewing ring of the 
valve after sizing and tied followed by de-airing 
and closure of left atrium. Patients were weaned 
from cardiopulmonary bypass. Cannulae were 
removed, drains were applied, the wound was 
closed, and patients were transmitted to ICU.
Table 1: Preoperative patients' data. Continuous data are presented as mean and standard deviation and categorical 
variables as number and percent 
Group A (n= 30) Group B (n= 30) p 
Female 18 (60%) 19 (63.3%) 0.791 
Age (Years) 40.83 ± 12.29 36.90 ± 18.02 0.327 
Weight (Kg) 66.93 ± 14.55 68.63 ± 12.04 0.624 





18 (60 %) 
12 (40%) 
0.795 
Atrial fibrillation 15 (50%) 18 (60%) 0.436 






Minimal invasive group 
Patients were positioned supine for right 
anterolateral thoracotomy with the right side 
elevated by putting a small pillow under the right 
scapula, and the right arm was slightly abducted to 
clear the axilla. Standard hemodynamic 
monitoring was done as usual in open-heart 
surgery. External defibrillator pads were applied. 
A measured 4-6 cm right anterolateral, 
inframammary incision was made, and the thorax 
was entered through the fourth intercostals 
space. Cardiopulmonary bypass was established 
through cannulation of the femoral artery and 
vein. Arterial inflow was established with the use 
of a flexible cannula size of 12-14F, and the 
femoral vein was cannulated with a multi-stage 
venous cannula size 22-24 F. The pericardium was 
opened longitudinally 3 cm parallel to the phrenic 
nerve and right side was suspended and fixed to 
skin by stay sutures which also helped in elevation 
of the left atrium. Cardiac arrest was induced by 
means of a newly designed transthoracic aortic 
cross-clamp inserted through a 4 mm incision in 
the third intercostal space (Chitwood, Scanlan 
International, Inc, Saint Paul, Minnesota, USA) or 
flexible (Cosgrove, Edwards Life science, Irvine, 
California, USA) clamp inserted through 
thoracotomy incision, and antegrade cold blood 
cardioplegia was used by intermittent manner 
directly through an aortic root. Systemic 
cardiopulmonary perfusion was maintained 
between 26 ° and 28°C throughout the cardiac 
arrest. Either a 5 or 10 mm thoracoscope (0-
degree or 30-degree view), connected to a three-
chip Linvatec camera was inserted through a port 
placed through the fourth or fifth intercostal 
space. Most frequently, a 5mm telescope was 
passed into the heart through a 3 to 4 cm left 
atriotomy, made just anterior to the superior 
pulmonary vein and traction was done by using 
specialized left atrial elevator designed for 
minimal invasive cardiac surgery and usually 
introduced to the chest through a small 
parasternal opening at level of 4th costal cartilage. 
A combination of both direct and thoracoscopic 
vision was done. Diseased valves were excised, 
and sutures were applied to annulus then to the 
sewing ring of the chosen prosthetic valve 
according to size. Atriotomy closure often was 
done by direct vision after de-airing. Patients were 
weaned from cardiopulmonary bypass, femoral 
artery and vein were repaired, drains were 
applied, the wound was closed, and patients were 
transmitted to ICU. 
Definitions 
Pain score  
We used the visual analog scale (VAS) to 
measure the degree of pain and differences 
between both groups. VAS is an instrument used 
to measure pain, it has multiple forms, and is 
mostly presented by the unidirectional distance 
between two points, either horizontal or vertical, 
and divided to ten centimeters in length where 
zero-point refers to no pain and ten-point refers to 
the worst pain. The patient will put the point at a 
distance referring to his pain, and patients were 
asked to put a number, which refers to the degree 
of pain. 
Statistical Analysis 
We reported continuous variables as mean± 
standard deviation (SD) and compared them with 
the Student t-test. Categorical data were 
expressed as frequency and percentage and were 
analyzed by Chi-square or Fisher’s exact tests if 
needed. All statistics were performed by SPSS 
software (Version 22, IBM Co., Armonk, NY, USA). 
Results 
Operative data 
There was one mortality in the conventional 
sternotomy group (3.3%) because of prosthetic 
valve endocarditis four months postoperatively. In 
contrast, no mortality was reported in the 
minimally invasive group (p<0.05). Intraoperative 
outcomes were summarized in Table 2 and Table 
3. One patient who underwent minimally invasive
surgery had a moderate hydrocoele due to 
lymphatic injury, which resolved entirely with the 
administration of anti-inflammatory drugs locally 
and systemic without the need for any surgical 
procedures. Another case suffered from an acute 
right lower limb ischemia in the second day 
postoperatively due to small clot, which removed 
by urgent embolectomy by the vascular surgeon 
with no residual disability, while 4 cases with 
sternotomy developed mediastinitis.  No patient 
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Table 2: Operative and early postoperative data. Continuous data are presented as mean and standard deviation 
Group A (n= 30) Group B (n= 30) P 
CPB time (minutes) 64.73 ± 19.16 118.93 ± 29.84 <0.001 
Cross-clamp time (min) 53.67 ± 18.46 102.27 ± 30.03 <0.001 
Ventilation time (hours) 6.28 ± 4.48 2.77 ± 2.27 <0.001 
Bleeding (ml) 841.67 ± 302.03 353.33 ± 146.77 <0.001 
Blood transfusion (units) 2.83 ± 1.34 0.50 ± 0.63 <0.001 
CPB: cardiopulmonary bypass 
Results of pain score measurement by VAS 
Postoperative pain was presented in Table 4. 
The pain score above 5 was significantly higher in 
group A (p= 0.037). 
Discussion 
Less invasive approaches for mitral valve 
surgery have been developed to decrease 
morbidities and enhance postoperative recovery 
in comparison to the conventional methods. One 
major advantage of the minimally invasive cardiac 
surgery is the decrease in the amount of bleeding; 
consequently, this reduced the need for blood 
transfusion in ICU. In our study, the sternotomy 
group needed higher amounts of blood 
transfusion, and these results are consistent with 
the results published by many authors [9 - 10]. In 
our work, 2 cases in group B (6.6%) had re-
exploration for bleeding.  
The lower amount of bleeding that occurred 
with the minimally invasive incision may be the 
result of the smaller incision. It is possible to stop 
bleeding from a minimally invasive incision during 
entry, whereas sternal bleeding from a standard 
sternotomy continues throughout the operative 
procedures, and the shed blood is retrieved from 
the pericardial sac. It is recognized that contact 
with a pleural or pericardial surface depletes 
fibrinogen, and by avoiding this bleeding and 
contact with the pleuropericardial surface, the 
clotting cascade is not activated. It is suspected 
that a sternotomy will continue to bleed into the 
mediastinum, even after it has been re-
approximated. A combination of these two factors 
likely accounts for the diminished bleeding and 
transfusion requirements with the minimally 
invasive approach.  
Both mean ICU and hospital stays were shorter 
in the minimally invasive group, and this did not 
differ significantly from the results published by 
Carpentier and his colleagues, and Cohn and his 
colleagues [11,12]. The prolonged time of 
hospital stay in conventional group was due to 
complicated cases as each case of mediastinitis 
discharged after more than thirty days, another 
two cases in sternotomy group discharged after 
20 days when the targeted INR was reached, and 
one case in the same group suffered from rapid 
atrial fibrillation before discharge and needed 
readmission in ICU for four days. 
Our results showed a marked reduction in pain 
score in the minimally invasive group compared to 
the sternotomy group, and it was only localized to 
the anterior part of the chest, which made 
postoperative pulmonary care easy and effective 
and translated to early mobilization.
Table 3: Postoperative data. Continuous data are presented as mean and standard deviation and categorical data as 
number and percent 
Group A (n= 30) Group B (n= 30) P 
ICU stay (days) 4.47 ± 0.94 1.73 ± 0.64 <0.001 
Hospital stay (days) 13.27 ± 7.62 6.13 ± 1.59 <0.001 
Re-exploration for bleeding 4 (13.3%) 2 (6.7%) 0.671 
Femoral complications 0 2 (6.7%) 0.492 
Mediastinitis 4 (13.3%) 0 0.112 




 Postoperative pain and quality of life were 
evaluated by the Leipzig group from 1996 to 1997 
using different scoring systems and showed a 
marked reduction in postoperative pain in the 
minimally invasive group [13]. Reduction of pain 
in group B was proposed to be due to avoidance 
of cutting the sternum, which was retracted for a 
long time and may be associated with a fracture or 
unequal division. Additionally, wires could cause 
pain in some cases. 
Table 4: Postoperative pain analysis by the visual 
analog scale 
Pain scale Group A (n= 30) Group B (n= 30) 
0 0 0 
2 3 (10%) 6 (20%) 
4 9 (30%) 15 (50%) 
6 15 (50%) 7 (23.3%) 
8 3 (10%) 2 (6.67%) 
10 0 0 
Regarding postoperative pulmonary 
complications, Mohr and colleagues reported 2 
mortalities from severe pneumonia at the 6th 
postoperative day in one case and from a 
pulmonary embolism on the 24th postoperative 
day, despite adequate anticoagulation [14]. In 
our group of minimally invasive approaches, no 
pulmonary complications were reported. 
In our study, we found that bypass time and 
aortic cross-clamping time were longer in cases 
operated via minimally invasive technique; these 
results are consistent with what Carpentier and 
colleagues reported [8]. 
An essential item is the neurological 
complications, which present major complications 
of minimally invasive mitral valve surgery because 
of inadequate de-airing; however, in our cases, 
there were no neurological complications, which 
is similar to what was reported by Grossi and 
colleagues [15]. Additionally, in a study of 1604 
consecutive patients who underwent minimally 
invasive surgery through a right anterolateral 
thoracotomy, no neurological complications were 
reported [16]. On the other hand, prolonged 
cross-clamp and cardiopulmonary bypass times 
were associated with a higher incidence of 
neurological events. Gaudiani and associates 
reported no difference in the rate of stroke 
between minimally invasive vs. conventional 
approaches [17].  
There was no wound infection in all cases 
operated through the minimally invasive 
techniques, while mediastinitis occurred in two 
cases in group A (6.6%). Mediastinitis was 
reported in 0.9% for mini-thoracotomy and 5.7% 
for sternotomy cases. This had increased to 1.8% 
and 7.7% in elderly patients, respectively [18]. 
Study limitations 
The study has several limitations, including a 
lack of randomization, small sample size, and 
single-center experience. However, the study 
showed the safety and feasibility of the minimally 
invasive approach compared to the conventional 
technique. 
Conclusion 
Video-assisted minimally invasive mitral 
operations could be a safe alternative to 
conventional sternotomy with the potential of 
lesser morbidity and earlier hospital discharge. 
Conflict of interest: Authors declare no conflict of 
interest. 
References 
1. Cosgrove DM, Sabik JF. Minimally invasive
approach for aortic valve operations. Ann
Thorac Surg. 1996; 62:596-7.
2. Cosgrove DM, Sabik JF, Navia JL. Minimally
invasive valve operations. Ann Thorac Surg.
1998; 65 (6): 1535-1539
3. Koenertz W, Waldenberger F, Schutzler M,
Ritter J, Liu J. Minimal access valve surgery
through superior partial sternotomy: a
preliminary study. J Heart Valve Dis. 1996;
5:638-40.
4. Navia JL, Cosgrove DM. Minimally invasive
mitral valve operations. Ann Thorac Surg 1996;
62:1542-4.
5. Pompili MF, Stevens JH, Burdon TA, et al. Port-
access mitral valve replacement in dogs. J
Thorac Cardiovasc Surg. 1996; 112:1268-74.
6. Lytle BW. Minimally invasive cardiac surgery. J






7. Mavroudis C. VATS ASD closure: A time not yet
come. Ann Thorac Surg. 1996; 62:638-9
8. A. Carpentier, D. Loulmet., First open-heart
operation (mitral valvuloplasty) under video
surgery through a mini-thoracotomy. Comptes
Rendus De L'Academie des Sciences: Sciences
de la vie. 1996; 319: 219–223.
9. Cosgrove DM, Sabik JF. A minimally invasive
approach for aortic valve operations. Ann
Thorac Surg. 1996; 62: 596–7
10. Mohr FM, Falk V, Diegeler A, et al. Computer-
enhanced “robotic” cardiac surgery:
experience in 148 patients. Journal of Thoracic
and Cardiovascular Surgery. 2001; 121 (5):
842-53
11. Carpentier A, Loulmet D, Aupècle B, et al.
Computer-assisted open-heart surgery the
first case operated on with success. Comptes
rendus de l'Academie des sciences. Serie III,
Sciences de la vie. 1998; 321 (5): 437– 42.
12. Cohn LH, Adams DH, Couper GS, et al.
Minimally invasive cardiac valve surgery
improves patient satisfaction while reducing
costs of cardiac valve replacement and repair.
Annals of Surgery. 1997; 226 (4): 421–428.
13. Walther T, Falk V, Metz S, et al. Pain and
quality of life after minimally invasive versus
conventional cardiac surgery. Ann Thorac 
Surg. 1999; 67:1643–1647.  
14. Mohr FW, Falk V, Diegeler A, et al. Minimally
invasive port-access mitral valve surgery. J
Thorac Cardiovasc Surg. 1998; 115 (3):567-576
21.
15. Grossi EA, Loulmet DF, Schwartz CF, et al.
Minimally invasive valve surgery with
antegrade perfusion strategy is not associated
with increased neurologic complications. The
Annals of Thoracic Surgery. 2011; 92 (4): 1346–
1350. 
16. Grossi EA, LaPietra A, Ribakove GH, et al.
Minimally invasive versus sternotomy
approaches for mitral reconstruction:
comparison of intermediate-term results. J
Thorac Cardiovasc Surg. 2001; 121 (4): 708–
713. 
17. Gaudiani VA, Grunkemeier GL, Castro LJ, Fisher
AL, Wu Y. Mitral valve operations through
standard and smaller incisions. Heart Surg
Forum. 2004; 7 (4): E337–E342.
18. Schwartz DS, Ribakove GH, Grossi EA, et al.
Minimally invasive mitral valve replacement:
port access technique, feasibility, and
myocardial functional preservation. J Thorac
Cardiovasc Surg. 1997; 113 (6): 1022–1030.
The Egyptian Cardiothoracic Surgeon 
In
Pr
e
s
